Abstract:Objective To explore the effect of delaying atrophy of mice denervated skeletal muscles by lentivirus mediated gene transfer of cardiotrophin-1. Methods Thirty-six Swiss mice were randomly divided into experimental group and control group, with 18 each. A model of gastrocnemius muscle denervation atrophy was established at the right lower limb by transecting the tibial nerve. Deaervated gastrocnemius muscles of the experimental group and control group were administered with 20 μl ( 108 TU/ml) of recombinant lentivirus vector carrying CT-1 eDNA and with 20 μl of Lenti-GFP solution respectively. Two and 4 weeks following the transfection, 3 mice each were checked for transection efficacy by observing expression of green fluorescent protein (GFP) under fluorescent microscope. Westem blot assays were done to validate the expression of CT-1.Twitch tension and tetanie tension, muzzle wet weight preservation rate, muscle fiber cross-sectional area and ultrastruture of the denervated muscles were measured and observed in 6 mice at each timepoint to evaluate the extent of muscle atrophy. Results Strong GFP expression was observed in the gastrocnemius muscles of both groups at 2 and 4 weeks following lentivirus transfeetion. Westem blot showed significantly inereaticl expression of CT-1 in the experimental group compared with the control group ( P < 0.01 ). Two weeks after transfection,twitch tension and tetanic tension, muscle wet weight preservation rate and muscle fiber cross-sectional area of the denervated muscles in the experimental group were (47.61 ± 6.25) %, (56.08 ± 5.47) %, (63.02 ± 5.23) %and (1372.42+ 149.73)μm2 respectively, being significantly higher than those in the control group, which were (27.23±5.06)%,(30.78±4.67)%,(52.41±4.98)%and(1147.28±128.67)μm2 respectively(all P <0.01).At 4 weeks.the above-mendoned parameters were(33.13±4.76)%,(36.59 4-5.67)%.(51.46-±5.36)%,and(1209.12±142.57)μm2 respectively in the experimental group,being significantly greater than these in the control group which were(16.40±5.48)%,(15.35±4.08)%,(39.15±6.12)%and (989.45 4-136.12)μm2 respectively(all P<0.01).Dilation of the sareoplasmic refieulum of denervated muscles in the experimental group wss markedly alleviated.Conclusion Lentivirus mediated gene therapy can aehieve high transection efficacy.CT-1 gene tmnsfeefion call produce llighly egieient and sustained CT-1 secretion in vivo and delay denervation indueed skeletal muscle atrophy for at least 4 weeks.

Expression patterns of miRNA-1 and miRNA-133 in the myocytes of denervated gastrocnemius in rat

Expression pattern of cardiotrophin-1 and its receptor in denervated skeletal muscles

The Effect of High Expression of Myogenic Differentiation Factor D in Muscle Satellite Cells on Prevention of Denervation Muscle Atrophy: an Experimental Study in Rats

Implantation of Muscle Satellite Cells Overexpressing Myogenin Improves Denervated Muscle Atrophy in Rats

The Study of Myogenin Expression in Denervated Human Skeletal Muscles

Microarray Analysis of Gene Expression Provides New Insights Into Denervation-Induced Skeletal Muscle Atrophy

[Experimental Study of Morphology and Electrophysiology on Denervated Skeletal Muscle].

Microrna133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells.

Decrease in the expression of muscle-specific miRNAs, miR-133a and miR-1, in myoblasts with replicative senescence

Muscle Atrophy and mRNA-miRNA Network Analysis of Vascular Endothelial Growth Factor (VEGF) in a Mouse Model of Denervation-Induced Disuse

Changes of Gene Expression Patterns of Muscle Pathophysiology-Related Transcription Factors During Denervated Muscle Atrophy

Identification of Potential Micrornas and KEGG Pathways in Denervation Muscle Atrophy Based on Meta-Analysis

Delaying denervated skeletal muscle atrophy in mice

[Ultrastructural Changes after Denervation of Different Muscles].

MyoD and Myf-5 Protein Expression in Denervated Human Skeletal Muscle

The Whole Transcriptome Involved in Denervated Muscle Atrophy Following Peripheral Nerve Injury

Expression Profiles of MiRNAs for Intrinsic Musculature of the Forepaw and Biceps in the Rat Model Simulating Irreversible Muscular Atrophy of Obstetric Brachial Plexus Palsy.

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

miR-30 Family microRNAs Regulate Myogenic Differentiation and Provide Negative Feedback on the microRNA Pathway

MicroRNA-142a-3p Regulates Neurogenic Skeletal Muscle Atrophy by Targeting Mef2a

Effects of Denervation on Expression of Carbonic Anhydrase Ⅲ and Its Phosphatase Activity in Skeletal Muscle of Rats